FDA Inspection
Sarepta Therapeutics IncSarepta Therapeutics Inc – FDA Inspection, Mar 24, 2023
Record Details
This FDA Inspection record concerns Sarepta Therapeutics Inc, with an inspection on March 24, 2023, issued by the New England District Office.
- Company
- Sarepta Therapeutics Inc
- Inspection Date
- March 24, 2023
View Company Profile
ID · f2328570-0fa3-42c6-be66-01a192cca9cc
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1200687
- FDA center
- Biologics
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.22(a)Authority lacking to review records, investigate errors
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Sarepta Therapeutics Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| July 15, 2025 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Sarepta Therapeutics Inc
- FDA Inspection 1277727 - 2025-07-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.